RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
New Iberia, LA · Shreveport, LA · +33 more sites
2 recruiting crohn's disease studies with a site in New Iberia, LA.
Sponsor: Eli Lilly and Company
New Iberia, LA · Shreveport, LA · +33 more sites
Sponsor: Sanofi
Baton Rouge, LA · Houma, LA · Mandeville, LA · +122 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.